Adventures in vascular biology: a tale of two mediators

被引:72
作者
Moncada, S. [1 ]
机构
[1] UCL, Wolfson Inst Biomed Res, London WC1E 6BT, England
关键词
prostacyclin; aspirin; nitric oxide; oxidative stress; free radicals; cardiovascular pathology;
D O I
10.1098/rstb.2005.1775
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
I would like to thank the Royal Society for inviting me to deliver the Croonian Lecture. In so doing, the Society is adding my name to a list of very distinguished scientists who, since 1738, have preceded me in this task. This is, indeed, a great honour. For most of my research career my main interest has been the understanding of the normal functioning of the blood vessel wall and the way this is affected in pathology. During this time, our knowledge of these subjects has grown to such an extent that many people now believe that the conquering of vascular disease is a real possibility in the foreseeable future. My lecture concerns the discovery of two substances, prostacyclin and nitric oxide. I would like to describe the moments of insight and some of the critical experiments that contributed significantly to the uncovering of their roles in vascular biology. The process was often adventurous, hence the title of this lecture. It is the excitement of the adventure that I would like to convey in the text that follows.
引用
收藏
页码:735 / 759
页数:25
相关论文
共 246 条
[1]   The induction of cyclooxygenase-2 by 17β-estradiol in endothelial cells is mediated through protein kinase C [J].
Akarasereenont, P ;
Techatraisak, K ;
Thaworn, A ;
Chotewuttakorn, S .
INFLAMMATION RESEARCH, 2000, 49 (09) :460-465
[2]   Nitric oxide synthases: structure, function and inhibition [J].
Alderton, WK ;
Cooper, CE ;
Knowles, RG .
BIOCHEMICAL JOURNAL, 2001, 357 (03) :593-615
[3]   Nitric oxide switches on glycolysis through the AMP protein kinase and 6-phosphofructo-2-kinase pathway [J].
Almeida, A ;
Moncada, S ;
Bolaños, JP .
NATURE CELL BIOLOGY, 2004, 6 (01) :45-U9
[4]   NITRIC-OXIDE SYNTHESIZED FROM L-ARGININE REGULATES VASCULAR TONE IN THE CORONARY CIRCULATION OF THE RABBIT [J].
AMEZCUA, JL ;
PALMER, RMJ ;
DESOUZA, BM ;
MONCADA, S .
BRITISH JOURNAL OF PHARMACOLOGY, 1989, 97 (04) :1119-1124
[5]   PROLONGED PARADOXICAL EFFECT OF ASPIRIN ON PLATELET BEHAVIOR AND BLEEDING-TIME IN MAN [J].
AMEZCUA, JL ;
OGRADY, J ;
SALMON, JA ;
MONCADA, S .
THROMBOSIS RESEARCH, 1979, 16 (1-2) :69-79
[6]   Clinical impact of vasomotor function assessment and the role of ACE-inhibitors and statins [J].
Asselbergs, FW ;
van der Harst, P ;
Jessurun, GAJ ;
Tio, RA ;
van Gilst, WH .
VASCULAR PHARMACOLOGY, 2005, 42 (03) :125-140
[7]  
AXELROD L, 1983, LANCET, V1, P904
[8]   ENDOTHELIUM-DEPENDENT INHIBITION OF PLATELET-AGGREGATION [J].
AZUMA, H ;
ISHIKAWA, M ;
SEKIZAKI, S .
BRITISH JOURNAL OF PHARMACOLOGY, 1986, 88 (02) :411-415
[9]  
Baigent C, 2002, BMJ-BRIT MED J, V324, P71, DOI 10.1136/bmj.324.7329.71
[10]   Selective cyclooxygenase 2 inhibitors, aspirin, and cardiovascular disease - A reappraisal [J].
Baigent, C ;
Patrono, C .
ARTHRITIS AND RHEUMATISM, 2003, 48 (01) :12-20